Intensive blood pressure control appears to be effective and safe in patients with peripheral artery disease: the Systolic Blood Pressure Intervention Trial.

Pubmed ID: 32853332

Pubmed Central ID: PMC8141296

Journal: European heart journal. Cardiovascular pharmacotherapy

Publication Date: May 23, 2021

MeSH Terms: Humans, Hypertension, Blood Pressure, Peripheral Arterial Disease, Antihypertensive Agents

Authors: Olsen MH, Biering-Sørensen T, Bhatt DL, Vaduganathan M, Pareek M, Byrne C, Olesen TB, Frary JMC, Rujic D, Kragholm KH

Cite As: Frary JMC, Pareek M, Byrne C, Vaduganathan M, Biering-Sørensen T, Rujic D, Kragholm KH, Olesen TB, Olsen MH, Bhatt DL. Intensive blood pressure control appears to be effective and safe in patients with peripheral artery disease: the Systolic Blood Pressure Intervention Trial. Eur Heart J Cardiovasc Pharmacother 2021 May 23;7(3):e38-e40.

Studies:

Abstract